Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. (AS@WORK)

Pfizer

Status: Completed

Conditions: Ankylosing Spondylitis

Treatments: Drug: Enbrel

Study type: Observational

Funder types: Industry

Identifiers

NCT01421303

B1801053 (Other Identifier)

0881A3-4675

Details and patient eligibility

About

Patients with Ankylosing spondylitis more frequently discontinue work. This study measures the impact of Enbrel on work participation.

Full description

Purely descriptive

Enrollment: 80 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Active AS patients (as judged by the treating MD) who are currently employed.
• Patients who are scheduled by their rheumatologist to initiate treatment with Etanercept.

Exclusion criteria

• Patients who initiated a procedure for eligibility of work disability/pension.
• Patients with previous use of TNF-alpha inhibitors either in commercial use, or in a study for the treatment of AS or a related spondylarthropathy condition.

Trial design

80 participants in 1 patient group

AS patients who are working and treated with Enbrel

Treatment:

Drug: Enbrel